{
  "fileName": "EFTA00039312.pdf",
  "dataSet": "9",
  "documentType": "Bureau of Prisons policy manual",
  "dateOriginal": "2005-01-15",
  "summary": "This is a Bureau of Prisons (BOP) policy document (P6360.01) titled 'Pharmacy Services,' dated January 15, 2005. It outlines comprehensive procedures for pharmacy operations within federal prisons, including staffing, standards of operation, controlled substance management, and patient safety protocols. It is a standard operating procedure and contains no direct references to the Epstein case, individuals, or specific events. This document is a Bureau of Prisons (BOP) Program Statement (P6360.01) detailing comprehensive policies and procedures for pharmacy services and controlled substance management within federal correctional institutions. It outlines strict protocols for storage, inventory, dispensing, administration, and error reporting of medications, with a significant focus on DEA-controlled substances. This document is a Bureau of Prisons (BOP) policy statement (P6360.01) titled 'Medication Administration: Inmate Pharmacy Services' dated January 15, 2005. It outlines comprehensive procedures for medication management, error reporting, controlled substance handling (including methadone), and patient counseling within federal correctional institutions. It is a standard operating procedure and does not contain specific case information related to Jeffrey Epstein.",
  "persons": [
    {
      "name": "Chief Pharmacist",
      "role": "Bureau of Prisons Pharmacy Supervisor",
      "category": "staff",
      "context": "The primary official responsible for implementing and overseeing all pharmacy and controlled substance procedures, including inventories, audits, reporting, and disposal.",
      "mentionCount": 15
    },
    {
      "name": "Warden",
      "role": "Prison Warden",
      "category": "staff",
      "context": "The institutional head who must be notified of any theft or loss of controlled substances and who is responsible for reporting such incidents to the DEA.",
      "mentionCount": 2
    },
    {
      "name": "HSA",
      "role": "Health Services Administrator",
      "category": "staff",
      "context": "The health services supervisor who designates the chair of the Controlled Substances Inventory Team and receives memos regarding theft or loss of drugs.",
      "mentionCount": 2
    },
    {
      "name": "Medical Director",
      "category": "staff",
      "role": "BOP Medical Director",
      "context": "The official who must be contacted for guidance if an institution is without pharmacist services for more than three days.",
      "mentionCount": 1
    },
    {
      "name": "BOP Chief Pharmacist",
      "role": "Bureau-level Chief Pharmacist",
      "category": "staff",
      "context": "The national-level pharmacy official to whom quarterly reports are submitted and who can help identify available pharmacists.",
      "mentionCount": 3
    },
    {
      "name": "Chief Psychiatrist",
      "role": "Psychiatric Services Chief",
      "category": "staff",
      "context": "At Psychiatric Referral Centers, this official must be informed of inmate non-compliance with psychiatric medications.",
      "mentionCount": 1
    },
    {
      "name": "Chief of Psychology",
      "role": "Psychology Department Head",
      "category": "staff",
      "context": "One of the mental health staff who must be notified of inmate non-compliance with psychiatric medications.",
      "mentionCount": 1
    },
    {
      "name": "Special Agent-in-Charge",
      "role": "DEA Regional Special Agent-in-Charge",
      "category": "law enforcement",
      "context": "The DEA official from whom a facility must request written permission to self-dispose of controlled substances.",
      "mentionCount": 1
    },
    {
      "name": "Harley G. Lappin",
      "role": "Director of the Bureau of Prisons",
      "category": "legal",
      "context": "Appears as the signatory at the end of the Bureau of Prisons policy document, indicating his approval and authorship of the directive.",
      "mentionCount": 1
    }
  ],
  "connections": [
    {
      "person1": "Chief Pharmacist",
      "person2": "Warden",
      "relationshipType": "reporting line",
      "description": "The Chief Pharmacist must send a memo to the Warden regarding any theft or loss of controlled substances.",
      "strength": 2
    },
    {
      "person1": "Chief Pharmacist",
      "person2": "HSA",
      "relationshipType": "reporting line",
      "description": "The Chief Pharmacist sends documentation of drug theft/loss to the HSA for review and filing.",
      "strength": 2
    },
    {
      "person1": "Chief Pharmacist",
      "person2": "BOP Chief Pharmacist",
      "relationshipType": "reporting line",
      "description": "The institutional Chief Pharmacist submits quarterly controlled substance reports to the BOP Chief Pharmacist.",
      "strength": 3
    },
    {
      "person1": "Chief Psychiatrist",
      "person2": "Chief of Psychology",
      "relationshipType": "colleague",
      "description": "Both are listed as relevant mental health staff who must be notified of inmate non-compliance with psychiatric medications.",
      "strength": 2
    }
  ],
  "events": [],
  "locations": [],
  "keyFacts": [
    "This document is a standard Bureau of Prisons (BOP) policy manual for pharmacy services, dated January 15, 2005.",
    "It details procedures for managing controlled substances, including DEA registration, security, inventory, and record-keeping.",
    "The policy establishes roles such as the Chief Pharmacist and Health Services Administrator (HSA) with specific responsibilities for pharmacy operations.",
    "It references standard correctional and pharmaceutical guidelines but contains no information specific to Jeffrey Epstein, his associates, or his incarceration.",
    "This is a detailed Bureau of Prisons policy (P6360.01) governing all aspects of pharmacy operations and controlled substance management in federal prisons, dated January 15, 2005.",
    "The policy mandates extremely strict protocols for DEA-controlled substances, including secure storage, biennial and quarterly inventories, and specific reporting procedures for theft or loss directly to the DEA.",
    "Medication administration to inmates must be directly observed, with inmates required to show an empty mouth to prevent 'cheeking' (hiding medication).",
    "The document outlines a formal, blame-free Medication Error Program focused on system improvement, categorizing errors per American Society of Health Systems Pharmacists guidelines.",
    "Institutions without pharmacist services for more than three days must contact the BOP Medical Director for guidance, highlighting the critical role of pharmacy oversight.",
    "This is a standard Bureau of Prisons (BOP) policy document (P6360.01) on medication administration and pharmacy services for inmates, dated January 15, 2005.",
    "The document details procedures for medication error reporting, severity ratings (Level 0-6), and reviews involving the Chief Pharmacist and Quality Improvement Program (QIP) coordinator.",
    "It contains specific regulations for the use, storage, and licensing of methadone within BOP institutions for detoxification, treatment of pregnant inmates, and pain management.",
    "The policy outlines strict controls for needles and syringes, including shift inventories and secure storage separate from controlled substances.",
    "The document is signed by Harley G. Lappin, who was the Director of the Federal Bureau of Prisons at the time."
  ],
  "analyzedAt": "2026-02-11T14:09:18.263Z"
}